---
id: aha-pah-right-heart-2024
title: "2024 AHA Scientific Statement: Evaluation and Management of Right Heart Failure"
short_title: "Right Heart Failure"
organization: American Heart Association
country: United States
url: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001190
specialty: cardiology
guideline_type: scientific-statement
evidence_system: aha-grade
conditions:
  - Right Heart Failure
  - Right Ventricular Dysfunction
  - Pulmonary Hypertension
tags:
  - right heart failure
  - RV dysfunction
  - pulmonary hypertension
  - heart failure
publication_date: 2024-06-01
previous_version_date: 2018-04-01
status: current
supersedes: aha-rvf-2018
superseded_by: null
pdf_path: null
has_pdf: false
last_reviewed: 2025-01-01
---

## Scope

This scientific statement provides guidance on the evaluation and management of right heart failure (RHF), addressing etiology, diagnosis, and treatment approaches.

## Key Recommendations

### Etiologies of RHF
- Pressure overload: Pulmonary hypertension, pulmonary embolism, pulmonic stenosis
- Volume overload: Tricuspid regurgitation, left-to-right shunts
- Primary RV disease: ARVC, RV infarction
- Left heart failure with secondary RV involvement

### Diagnostic Evaluation
**Imaging:**
- Echocardiography: TAPSE, S', FAC, RV strain
- CMR: Gold standard for RV volumes and function
- CT for pulmonary pathology

**Right Heart Catheterization:**
- Essential for PH diagnosis
- Assess right atrial pressure, pulmonary artery pressures, cardiac output
- Calculate PVR

**Biomarkers:**
- BNP/NT-proBNP: Prognostic value
- Troponin in acute settings

### Management - General Principles
- Treat underlying cause
- Volume management: Diuretics to optimize preload
- Avoid excessive volume depletion
- Maintain blood pressure for RV perfusion

### Pharmacotherapy
**Diuretics:**
- Loop diuretics for congestion
- Add thiazide for diuretic resistance

**Inotropes/Vasopressors:**
- Dobutamine, milrinone for acute decompensation
- Norepinephrine or vasopressin if hypotensive

**PH-Specific Therapies:**
- Per PAH guidelines if applicable

### Device/Surgical Therapies
- ECMO or RVAD for refractory cases
- Transplant evaluation for advanced RHF

### Prognosis
- RV function is key prognostic determinant in many conditions
- Multidisciplinary care recommended
